LTFS
FBRX icon

Ladenburg Thalmann Financial Services’s Forte Biosciences FBRX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Hold
0
– – – 5378
2019
Q2 		– Sell
-1
Closed -$2K – 5314
2019
Q1 		$2K Buy
+1
New +$3.86K ﹤0.01% 4929

Other funds holding FBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ladenburg Thalmann Financial Services's FBRX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Forte Biosciences (FBRX) position steady in Q4 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5378.

Ladenburg Thalmann Financial Services first reported a position in FBRX in Q1 2019 and has held it in 1 quarter since. The position peaked at $2K in Q1 2019. 51 funds tracked by Wall St. Rank hold FBRX as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 0 shares of Forte Biosciences worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Forte Biosciences share count unchanged in Q4 2019.
  • Forte Biosciences made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5378 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Forte Biosciences in Q1 2019 and has held it in 1 quarter since.
  • Ladenburg Thalmann Financial Services's Forte Biosciences position peaked at $2K in Q1 2019.
  • 51 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.